Rankings
▼
Calendar
MDXG Q3 2024 Earnings — MiMedx Group, Inc. Revenue & Financial Results | Market Cap Arena
MDXG
MiMedx Group, Inc.
$684M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$84M
+2.9% YoY
Gross Profit
$69M
81.8% margin
Operating Income
$11M
13.3% margin
Net Income
$8M
9.6% margin
EPS (Diluted)
$0.05
QoQ Revenue Growth
-3.6%
Cash Flow
Operating Cash Flow
$20M
Free Cash Flow
$14M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$244M
Total Liabilities
$63M
Stockholders' Equity
$181M
Cash & Equivalents
$89M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$84M
$82M
+2.9%
Gross Profit
$69M
$67M
+2.7%
Operating Income
$11M
$11M
+0.3%
Net Income
$8M
$9M
-5.1%
Revenue Segments
Surgical
$29M
100%
← FY 2024
All Quarters
Q4 2024 →